Egan, James E <br/><br/>
IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro.  [electronic resource] 

 -  Journal of immunotherapy (Hagerstown, Md. : 1997)  Sep 2007 
 - 624-33 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1524-9557 
<br/><br/><label>Standard No.: </label>10.1097/CJI.0b013e3180691593  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD--metabolism<br/>Cell Differentiation<br/>Cell Shape--drug effects<br/>Cytokines--immunology<br/>Dendritic Cells--cytology<br/>Endocytosis--drug effects<br/>Humans<br/>Interleukin-12--immunology<br/>Lymphocyte Activation<br/>Lymphocyte Culture Test, Mixed<br/>Monocytes--cytology<br/>Receptors, CCR7<br/>Receptors, Chemokine--metabolism<br/>T-Lymphocytes--immunology